Wall Street has issued downbeat forecasts for the stocks in this article.
These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor.
The key risk, however, is that these stocks are usually cheap for a reason – five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.
Regarded as defensive investments, consumer staples stocks are generally safe bets in choppy markets. Unfortunately, the sector hasn’t provided much protection lately as it pulled back by 14% over the past six months. This performance was worse than the S&P 500’s 6.2% loss.
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets.
But the many opportunities in front of them attract significant competition, spanning from industry behemoths with seemingly infinite resources to small, nimble players with chips on their shoulders.
A company with profits isn’t always a great investment.
Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
The FDA and HHS are launching a national push to eliminate petroleum-based food dyes, starting with Citrus Red No. 2 and Orange B. The plan is part of Robert F. Kennedy Jr.'s "Make America Healthy Again" campaign to improve public health and food safety.
Stock market expert Jon Erlichman recently shared a review of stock returns during the last six U.S. recessions, highlighting those that have performed well in difficult times.
J. M. Smucker currently trades at $116.01 per share and has shown little upside over the past six months, posting a small loss of 1.9%. However, the stock is beating the S&P 500’s 7.3% decline during that period.
Volatility has swept the market following tariff announcements, with many recalculating their growth outlooks under the new regime. Recently, several stocks have ignored the market’s woes, showing relative strength.
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at shelf-stable food stocks, starting with J. M. Smucker (NYSE:SJM).
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Campbell's (NASDAQ:CPB) and the rest of the shelf-stable food stocks fared in Q4.
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor.
The key risk, however, is that these stocks are usually cheap for a reason – five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.
Stay informed about the performance of the S&P500 index in the middle of the day on Friday. Uncover the top gainers and losers in today's session for valuable insights.
Packaged foods company J.M Smucker (NYSE:SJM) fell short of the market’s revenue expectations in Q4 CY2024, with sales falling 1.9% year on year to $2.19 billion. Its non-GAAP profit of $2.61 per share was 10.3% above analysts’ consensus estimates.
